title: Up-regulation of alveolar macrophage platelet-derived growth factor-B (PDGF-B) mRNA by interferon-gamma from Mycobacterium tuberculosis antigen (PPD)-stimulated lymphocytes.
abstract: Macrophage production of PDGF-B is believed to be important in the pathogenesis of diseases where chronic lung inflammation develops into fibrosis. Since tuberculosis is characterized by chronic inflammation and tissue fibrosis, we asked if lymphokines from lymphocytes stimulated by the Mycobacterium tuberculosis antigen PPD, contained factors capable of increasing human alveolar macrophage PDGF-B mRNA. Supernatants from both phytohaemagglutinin (PHA)- and purified protein derivative (PPD)-stimulated lymphocytes, when added to macrophages, induced an increase in the mRNA of PDGF-B, but not transforming growth factor-beta (TGF-beta). When lymphocytes from contacts of patients with tuberculosis, patients with tuberculosis, and normal subjects were compared following PPD stimulation, the lymphocytes from the contacts had the greatest proliferation response, the greatest production of interferon-gamma (IFN-gamma), and their lymphokines induced the greatest increase in PDGF-B mRNA in macrophages. Recombinant human IFN-gamma reproduced this ability of lymphokines to increase macrophage PDGF-B mRNA. Finally, the increase in macrophage PDGF-B mRNA following incubation with supernatants from PPD-stimulated lymphocytes was shown to be due to IFN-gamma, when the increase in macrophage PDGF-B mRNA was prevented by addition of anti-human IFN-gamma antibody to the lymphocyte supernatant. This study indicated that antigen-stimulated lymphocytes released IFN-gamma, which in turn resulted in an increase in PDGF-B mRNA in alveolar macrophages. Such a mechanism provides a link between the DTH response and the first stages of a fibrotic reaction, and may offer an explanation for the progression of chronic inflammation to fibrosis, as occurs in the lungs of patients with untreated pulmonary tuberculosis.
authors.affiliation: Department of Respiratory Medicine, St. Mary's Hospital Medical School, London, UK.
authors.forename: A
authors.initials: A
authors.lastname: Wangoo
authors.forename: I K
authors.initials: IK
authors.lastname: Taylor
authors.forename: A R
authors.initials: AR
authors.lastname: Haynes
authors.forename: R J
authors.initials: RJ
authors.lastname: Shaw
mesh_terms: D001483:Base Sequence; D003208:Concanavalin A / Q000494:pharmacology; D006684:HLA-DR Antigens / Q000235:genetics; D006801:Humans; D007371:Interferon-gamma / Q000502:physiology*; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology; D016676:Macrophages, Alveolar / Q000378:metabolism*; D008969:Molecular Sequence Data; D010835:Phytohemagglutinins / Q000494:pharmacology; D010982:Platelet-Derived Growth Factor / Q000235:genetics*; D012333:RNA, Messenger / Q000032:analysis* / Q000235:genetics; D014373:Tuberculin / Q000276:immunology*; D015854:Up-Regulation
chemical_list: D006684:HLA-DR Antigens; D010835:Phytohemagglutinins; D010982:Platelet-Derived Growth Factor; D012333:RNA, Messenger; D014373:Tuberculin; D003208:Concanavalin A; D007371:Interferon-gamma